Jounce Therapeutics, Inc.
JNCE · NASDAQ
12/31/2022 | 9/30/2022 | 6/30/2022 | 3/31/2022 | |
|---|---|---|---|---|
| Operating Activities | – | – | – | – |
| Net Income | $50,959 | -$30,998 | -$33,513 | -$37,367 |
| Dep. & Amort. | $442 | $495 | $560 | $590 |
| Deferred Tax | $0 | $0 | $0 | $0 |
| Stock-Based Comp. | $2,441 | $2,560 | $2,443 | $2,829 |
| Change in WC | $5,247 | -$3,728 | $6,882 | $481 |
| Other Non-Cash | $145 | $131 | $223 | $301 |
| Operating Cash Flow | $59,234 | -$31,540 | -$23,405 | -$33,166 |
| Investing Activities | – | – | – | – |
| PP&E Inv. | -$223 | -$240 | -$349 | -$107 |
| Net Acquisitions | $0 | $0 | $0 | $0 |
| Inv. Purchases | $0 | $0 | $0 | -$24,928 |
| Inv. Sales/Matur. | $14,450 | $31,150 | $41,050 | $22,675 |
| Other Inv. Act. | $0 | $0 | $0 | $0 |
| Investing Cash Flow | $14,227 | $30,910 | $40,701 | -$2,360 |
| Financing Activities | – | – | – | – |
| Debt Repay. | $0 | $0 | $0 | $0 |
| Stock Issued | $442 | $0 | $0 | $0 |
| Stock Repurch. | $0 | $0 | $0 | $0 |
| Dividends Paid | $0 | $0 | $0 | $0 |
| Other Fin. Act. | -$442 | $0 | $33 | $409 |
| Financing Cash Flow | $0 | $0 | $33 | $409 |
| Forex Effect | $0 | $0 | $0 | $0 |
| Net Chg. in Cash | $73,461 | -$630 | $17,329 | -$35,117 |
| Supplemental Information | – | – | – | – |
| Beg. Cash | $78,381 | $79,011 | $61,682 | $96,799 |
| End Cash | $151,842 | $78,381 | $79,011 | $61,682 |
| Free Cash Flow | $59,011 | -$31,780 | -$23,754 | -$33,273 |